Actively Recruiting
Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance
Led by Universal Diagnostics · Updated on 2025-12-30
6500
Participants Needed
1
Research Sites
204 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is designed to prospectively collect blood samples and clinical data from patients that have been newly diagnosed with colorectal cancer and scheduled for resection surgery but are pre cancer treatment, subjects who are NOT scheduled for surgery but have histological confirmation of CRC from the diagnostic colonoscopy and clinical staging (cTMN) is available and are pr e- treatment, and patients who are at average risk of colorectal cancer and who are scheduled for routine colonoscopy examinations.
CONDITIONS
Official Title
Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with colorectal cancer (CRC) (Arm A)
- Undergoing screening with colonoscopy for colorectal cancer (Arm B)
You will not qualify if you...
- Undergoing treatment for colorectal cancer (Arm A)
- Past history of colorectal cancer (Arm B)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Gastroenterology and Internal Medicine Specialists
Lake Barrington, Illinois, United States, 60010
Actively Recruiting
Research Team
A
Antonio Jesus Merino Calvo
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here